Abstract
This is a letter in response to an article by Ahmed et al., which concluded that in comparison to salbutamol, Fluticasone/salmeterol combination increases FEV1, FEV1% of predicted, and FEV1/FVC ratio, however it did not offer novel insights, as both agents met the 12%- and 200-mL reversibility benchmarks and Concerns about incorporating a combination medication that includes an inhaled corticosteroid, inhaled corticosteroids are not typically associated with bronchodilation.
| Original language | English |
|---|---|
| Article number | 132 |
| Journal | BMC Pulmonary Medicine |
| Volume | 24 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 12-2024 |
All Science Journal Classification (ASJC) codes
- Pulmonary and Respiratory Medicine
Fingerprint
Dive into the research topics of 'Bronchodilator reversibility testing in morbidly obese non-smokers: a comparative study– few concerns'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver